X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
Other Certificates
Other Suppliers
0
USA (Orange Book)
0
Europe
Canada
0
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
100
PharmaCompass offers a list of Lornoxicam API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Lornoxicam manufacturer or Lornoxicam supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Lornoxicam manufacturer or Lornoxicam supplier.
PharmaCompass also assists you with knowing the Lornoxicam API Price utilized in the formulation of products. Lornoxicam API Price is not always fixed or binding as the Lornoxicam Price is obtained through a variety of data sources. The Lornoxicam Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Lornoxicam manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lornoxicam, including repackagers and relabelers. The FDA regulates Lornoxicam manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lornoxicam API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Lornoxicam manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Lornoxicam supplier is an individual or a company that provides Lornoxicam active pharmaceutical ingredient (API) or Lornoxicam finished formulations upon request. The Lornoxicam suppliers may include Lornoxicam API manufacturers, exporters, distributors and traders.
click here to find a list of Lornoxicam suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Lornoxicam DMF (Drug Master File) is a document detailing the whole manufacturing process of Lornoxicam active pharmaceutical ingredient (API) in detail. Different forms of Lornoxicam DMFs exist exist since differing nations have different regulations, such as Lornoxicam USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Lornoxicam DMF submitted to regulatory agencies in the US is known as a USDMF. Lornoxicam USDMF includes data on Lornoxicam's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Lornoxicam USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Lornoxicam suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Lornoxicam Drug Master File in Japan (Lornoxicam JDMF) empowers Lornoxicam API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Lornoxicam JDMF during the approval evaluation for pharmaceutical products. At the time of Lornoxicam JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Lornoxicam suppliers with JDMF on PharmaCompass.
A Lornoxicam written confirmation (Lornoxicam WC) is an official document issued by a regulatory agency to a Lornoxicam manufacturer, verifying that the manufacturing facility of a Lornoxicam active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Lornoxicam APIs or Lornoxicam finished pharmaceutical products to another nation, regulatory agencies frequently require a Lornoxicam WC (written confirmation) as part of the regulatory process.
click here to find a list of Lornoxicam suppliers with Written Confirmation (WC) on PharmaCompass.
Lornoxicam Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Lornoxicam GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Lornoxicam GMP manufacturer or Lornoxicam GMP API supplier for your needs.
A Lornoxicam CoA (Certificate of Analysis) is a formal document that attests to Lornoxicam's compliance with Lornoxicam specifications and serves as a tool for batch-level quality control.
Lornoxicam CoA mostly includes findings from lab analyses of a specific batch. For each Lornoxicam CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Lornoxicam may be tested according to a variety of international standards, such as European Pharmacopoeia (Lornoxicam EP), Lornoxicam JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Lornoxicam USP).
Market Place
